OTCMKTS:TRXD - Trxade Group Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started $0.50 0.00 (0.00 %) (As of 07/20/2018 02:31 AM ET)Previous Close$0.50Today's Range$0.50 - $0.5052-Week Range$0.22 - $1.00VolumeN/AAverage Volume317 shsMarket Capitalization$16 millionP/E RatioN/ADividend YieldN/ABeta0.61 Company ProfileAnalyst RatingsEarnings HistoryHeadlinesSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Trxade Group, Inc. owns and operates a business-to-business Web-based marketplace focused on the United States pharmaceutical industry. The company offers Web based market platform that enables trade among healthcare buyers and sellers of pharmaceuticals, accessories, and services. Its principal products and services include Trxade.com and InventoryRx.com, which are Web-based pharmaceutical marketplaces; Pharmabayonline that provides access to proprietary pharmaceutical data analytics to the United States-based independent pharmacies, pharmaceutical shortage databases, proposed governmental reimbursement benchmarks comparison and analysis, and a proprietary suggested national retail drug benchmark; and RxGuru, a service-based desktop software application, which provides daily drug pricing and analytics to the independent pharmacists. The company distributes its services through its online platform to independent pharmacies and pharmaceutical suppliers in 18 states of the United States. Trxade Group, Inc. is based in Land O' Lakes, Florida. Receive TRXD News and Ratings via Email Sign-up to receive the latest news and ratings for TRXD and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Drugs, proprietaries, & sundries Sub-IndustryN/A SectorRetail/Wholesale SymbolOTCMKTS:TRXD CUSIPN/A Webrx.trxade.com Phone800-261-0281 Debt Debt-to-Equity Ratio-2.11 Current Ratio1.46 Quick Ratio1.46 Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$2.93 million Price / Sales5.46 Cash Flow$0.0113 per share Price / Cash44.43 Book Value($0.01) per share Price / Book-50.00 Profitability EPS (Most Recent Fiscal Year)N/A Net Income$280,000.00 Net Margins9.57% Return on Equity-72.06% Return on Assets52.12% Miscellaneous Employees23 Outstanding Shares31,990,000Market Cap$16.00 Trxade Group (OTCMKTS:TRXD) Frequently Asked Questions What is Trxade Group's stock symbol? Trxade Group trades on the OTCMKTS under the ticker symbol "TRXD." How were Trxade Group's earnings last quarter? Trxade Group Inc (OTCMKTS:TRXD) announced its earnings results on Tuesday, March, 29th. The company reported ($0.02) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.01) by $0.01. The firm earned $1.15 million during the quarter, compared to analyst estimates of $1.35 million. Trxade Group had a net margin of 9.57% and a negative return on equity of 72.06%. View Trxade Group's Earnings History. What is the consensus analysts' recommendation for Trxade Group? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Trxade Group in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." Who are some of Trxade Group's key competitors? Some companies that are related to Trxade Group include McKesson (MCK), AmerisourceBergen (ABC), Cardinal Health (CAH), Herbalife Nutrition (HLF), Nu Skin Enterprises (NUS), PetIQ (PETQ), Aceto (ACET), biOasis Technologies (BIOAF) and Medizone International (MZEI). Who are Trxade Group's key executives? Trxade Group's management team includes the folowing people: Mr. Surendra K. Ajjarapu, Founder, Chairman, CEO & Sec. (Age 47)Mr. Prashant Patel, Founder, Pres, COO & Director (Age 44)Mr. Howard A. Doss, Chief Financial Officer (Age 64)Dr. Ramesh Kenchappa M.S.(Pharma), Ph.D., Chief Scientific OfficerMr. Steven D. Lee Esq., Gen. Counsel Has Trxade Group been receiving favorable news coverage? News headlines about TRXD stock have been trending positive on Friday, Accern Sentiment Analysis reports. The research firm identifies negative and positive news coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Trxade Group earned a media sentiment score of 0.26 on Accern's scale. They also gave press coverage about the company an impact score of 48.56 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the next several days. How do I buy shares of Trxade Group? Shares of TRXD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Trxade Group's stock price today? One share of TRXD stock can currently be purchased for approximately $0.50. How big of a company is Trxade Group? Trxade Group has a market capitalization of $16 million and generates $2.93 million in revenue each year. Trxade Group employs 23 workers across the globe. How can I contact Trxade Group? Trxade Group's mailing address is 3840 Land O' Lakes Blvd., Land O' Lakes FL, 34639. The company can be reached via phone at 800-261-0281 or via email at [email protected] MarketBeat Community Rating for Trxade Group (OTCMKTS TRXD)Community Ranking: 1.9 out of 5 ()Outperform Votes: 48 (Vote Outperform)Underperform Votes: 78 (Vote Underperform)Total Votes: 126MarketBeat's community ratings are surveys of what our community members think about Trxade Group and other stocks. Vote "Outperform" if you believe TRXD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TRXD will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/20/2018 by MarketBeat.com StaffFeatured Article: What does EPS mean?